Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Alume Biosciences

Request full access

On a mission to make proprietary nerve illumination technology available for surgeons so that patients everywhere can benefit

San Diego, United StatesFounded 2017Biotech & Life Sciences

About Alume Biosciences

Alume Biosciences is a biotechnology company that develops nerve-targeted drugs to improve surgical precision and preserve nerve function. The company's lead product, Bevonescein (ALM-488), is a peptide-dye conjugate designed to illuminate nerves during surgery, which is currently in Phase 3 clinical trials.

Alume Biosciences operates in the surgical and therapeutic pharmaceutical market, with a focus on providing solutions for surgeons to protect and preserve nerve function. The company's business model is centered around the development and commercialization of its proprietary nerve illumination technology. Alume Biosciences has secured $13 million in Series B financing to advance the clinical development of Bevonescein.

Source: Dealroom company data

At a glance

Status
Operational
Employees
17
Open positions
None listed
Dealroom signal
70.1/100
Industry
Health
Sub-industry
BioTechnology, Health Platform
Sector
Biotechnology, Surgery, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
SaaS
Client focus
B2B

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Jan 2023 $13M $52M Undisclosed ↗
GRANTOther financing Sep 2022 $3.4M — National Institute of Neurological Disorders and Stroke ↗
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Alume Biosciences website traffic

Latest recorded traffic for Alume Biosciences is 1.7K monthly website visits, up 41.7% over the last three months. Alume Biosciences's team declined 10.5% over the past year.

Latest monthly visits1.7K 3-month web change+41.7% 1-year team growth-10.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Alume Biosciences in the San Diego ecosystem

Live from Dealroom

The Alume Biosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

Other known investors2 additional known investors

  • University of California, San Diego
  • BioBrit
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Alume Biosciences on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Alume Biosciences’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.